Bredt David — SEC Form 4 filings
SEC reporting owner CIK 2022087. 16 Form 4 filings on record with FilingPulse; latest filed 2026-02-19.
Transaction summary — filings shown
Covers all 16 filings on record, filed 2024-06-10 to 2026-02-19. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 21 legs across 13 filings — 108,567 shares, $2,160,917 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 6.
- Largest priced transaction: sale of 7,704 shares @ $29.95 ($230,711) in Rapport Therapeutics, Inc., filed 2025-12-16.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Rapport Therapeutics, Inc. (RAPP) | Chief Scientific Officer | 16 | — | 21 legs · 108,567 sh · $2,160,917 | 6 |
Form 4 filings — Bredt David
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-02-19 | 4 | Rapport Therapeutics, Inc. (RAPP) | Sale (S): 900 @ $28.02 · Sale (S): 5,400 @ $28.95 · Sale (S): 2,200 @ $29.59 · Option exercise (M): 6,000 @ $1.80 · Option exercise (M): 6,000 (derivative) @ $0 | EDGAR |
| 2026-02-04 | 4 | Rapport Therapeutics, Inc. (RAPP) | Grant/award (A): 103,000 (derivative) @ $0 | EDGAR |
| 2026-01-16 | 4 | Rapport Therapeutics, Inc. (RAPP) | Sale (S): 8,300 @ $26.83 · Sale (S): 200 @ $27.40 | EDGAR |
| 2026-01-05 | 4 | Rapport Therapeutics, Inc. (RAPP) | Grant/award (A): 18,000 · Sale (S): 6,567 @ $30.05 | EDGAR |
| 2025-12-16 | 4 | Rapport Therapeutics, Inc. (RAPP) | Sale (S): 7,704 @ $29.95 · Sale (S): 796 @ $30.68 | EDGAR |
| 2025-11-18 | 4 | Rapport Therapeutics, Inc. (RAPP) | Sale (S): 3,156 @ $24.84 · Sale (S): 5,344 @ $25.39 | EDGAR |
| 2025-10-16 | 4 | Rapport Therapeutics, Inc. (RAPP) | Sale (S): 7,418 @ $25.73 · Sale (S): 1,082 @ $26.16 | EDGAR |
| 2025-09-17 | 4 | Rapport Therapeutics, Inc. (RAPP) | Sale (S): 5,098 @ $23.88 · Sale (S): 3,402 @ $24.66 | EDGAR |
| 2025-08-18 | 4 | Rapport Therapeutics, Inc. (RAPP) | Sale (S): 8,300 @ $14.98 · Sale (S): 200 @ $15.79 | EDGAR |
| 2025-07-16 | 4 | Rapport Therapeutics, Inc. (RAPP) | Sale (S): 8,500 @ $14.00 | EDGAR |
| 2025-06-18 | 4 | Rapport Therapeutics, Inc. (RAPP) | Sale (S): 8,500 @ $11.00 | EDGAR |
| 2025-05-19 | 4 | Rapport Therapeutics, Inc. (RAPP) | Sale (S): 8,500 @ $9.56 | EDGAR |
| 2025-04-16 | 4 | Rapport Therapeutics, Inc. (RAPP) | Sale (S): 8,500 @ $9.57 | EDGAR |
| 2025-03-17 | 4 | Rapport Therapeutics, Inc. (RAPP) | Sale (S): 8,500 @ $10.85 | EDGAR |
| 2025-02-04 | 4 | Rapport Therapeutics, Inc. (RAPP) | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2024-06-10 | 4 | Rapport Therapeutics, Inc. (RAPP) | Grant/award (A): 28,302 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2022087 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →